3 Result(s)

Article

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Overall survival (OS) benefits of neoadjuvant immunotherapy remain elusive in locally advanced esophageal squamous cell carcinomas (ESCC). Here, we reported the results of a phase 1b trial of neoadjuvant PD-L1...

Jun Yin, **gnan Yuan, Yun** Li, Yong Fang, Ruoxi Wang, Heng Jiao… in Nature Medicine (2023)

Article

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Jun Yin, **gnan Yuan, Yun** Li, Yong Fang, Ruoxi Wang, Heng Jiao… in Nature Medicine (2023)

Article

Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation

Esophageal squamous cell carcinoma (ESCC) is a prevalent tumor in the gastrointestinal tract, but our understanding of the molecular mechanisms underlying ESCC remains incomplete. Existing studies indicate tha...

Jianmin Gu, Shaoyuan Zhang, Dong Lin, Wenhan Wang, **ke Cheng… in Cellular Oncology (2024)